LYMECYCLINE: 174 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
174
Total FAERS Reports
0
Deaths Reported
68
Hospitalizations
174
As Primary/Secondary Suspect
14
Life-Threatening
1
Disabilities
First Report: 20070622 · Latest Report: 20250731
What Are the Most Common LYMECYCLINE Side Effects?
#1 Most Reported
Product use in unapproved indication
16 reports (9.2%)
#2 Most Reported
Drug ineffective
16 reports (9.2%)
#3 Most Reported
Headache
12 reports (6.9%)
All LYMECYCLINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 16 | 9.2% | 0 | 1 |
| Product use in unapproved indication | 16 | 9.2% | 0 | 0 |
| Headache | 12 | 6.9% | 0 | 10 |
| Thrombocytopenia | 11 | 6.3% | 0 | 0 |
| Myocarditis | 10 | 5.8% | 0 | 9 |
| Chest pain | 9 | 5.2% | 0 | 9 |
| Hypersensitivity | 9 | 5.2% | 0 | 7 |
| Cholestasis | 8 | 4.6% | 0 | 8 |
| Contraindicated product administered | 8 | 4.6% | 0 | 8 |
| Dry skin | 8 | 4.6% | 0 | 1 |
| Foetal exposure during pregnancy | 8 | 4.6% | 0 | 1 |
| Folliculitis | 8 | 4.6% | 0 | 3 |
| Interstitial lung disease | 8 | 4.6% | 0 | 0 |
| Intracranial pressure increased | 8 | 4.6% | 0 | 8 |
| Off label use | 8 | 4.6% | 0 | 0 |
| Pulmonary embolism | 8 | 4.6% | 0 | 0 |
| Rash maculo-papular | 8 | 4.6% | 0 | 8 |
| Dermatitis contact | 7 | 4.0% | 0 | 0 |
| Drug ineffective for unapproved indication | 7 | 4.0% | 0 | 0 |
| Drug reaction with eosinophilia and systemic symptoms | 7 | 4.0% | 0 | 6 |
Who Reports LYMECYCLINE Side Effects? Age & Gender Data
Gender: 60.6% female, 39.4% male. Average age: 37.4 years. Most reports from: GB. View detailed demographics →
Is LYMECYCLINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2007 | 10 | 0 | 0 |
| 2013 | 7 | 0 | 7 |
| 2014 | 4 | 0 | 2 |
| 2015 | 5 | 0 | 3 |
| 2016 | 9 | 0 | 6 |
| 2017 | 5 | 0 | 3 |
| 2018 | 22 | 0 | 19 |
| 2019 | 19 | 0 | 8 |
| 2020 | 4 | 0 | 0 |
| 2021 | 7 | 0 | 1 |
| 2022 | 1 | 0 | 0 |
| 2023 | 5 | 0 | 2 |
| 2025 | 11 | 0 | 3 |
What Is LYMECYCLINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 46 |
| Acne | 38 |
| Folliculitis | 10 |
| Skin disorder | 10 |
| Colorectal cancer metastatic | 6 |
| Rosacea | 6 |
| Hidradenitis | 5 |
LYMECYCLINE vs Alternatives: Which Is Safer?
LYMECYCLINE vs LYRICA
LYMECYCLINE vs LYSERGIDE
LYMECYCLINE vs MABTHERA
LYMECYCLINE vs MACITENTAN
LYMECYCLINE vs MACITENTAN\TADALAFIL
LYMECYCLINE vs MAGNESIUM
LYMECYCLINE vs MAGNESIUM ASPARTATE
LYMECYCLINE vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
LYMECYCLINE vs MAGNESIUM HYDROXIDE
LYMECYCLINE vs MAGNESIUM OROTATE
Official FDA Label for LYMECYCLINE
Official prescribing information from the FDA-approved drug label.